These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7616401

  • 41. Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats.
    Finn IB, Holtzman SG.
    Life Sci; 1988; 42(24):2475-82. PubMed ID: 3374267
    [Abstract] [Full Text] [Related]

  • 42. Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys.
    Holtzman SG.
    Eur J Pharmacol; 1999 Jul 02; 376(1-2):7-15. PubMed ID: 10440083
    [Abstract] [Full Text] [Related]

  • 43. Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
    Howell LL, Byrd LD.
    J Pharmacol Exp Ther; 1993 Oct 02; 267(1):432-9. PubMed ID: 8229772
    [Abstract] [Full Text] [Related]

  • 44. Differences between the nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood effects: studies using medium to high doses in animal models.
    López-Cruz L, Pardo M, Salamone JD, Correa M.
    Behav Brain Res; 2014 Aug 15; 270():213-22. PubMed ID: 24859174
    [Abstract] [Full Text] [Related]

  • 45. Chronic effects of xanthines on levels of central receptors in mice.
    Shi D, Daly JW.
    Cell Mol Neurobiol; 1999 Dec 15; 19(6):719-32. PubMed ID: 10456233
    [Abstract] [Full Text] [Related]

  • 46. Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').
    Vanattou-Saïfoudine N, McNamara R, Harkin A.
    Psychopharmacology (Berl); 2010 Jul 15; 211(1):15-25. PubMed ID: 20437223
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Disclosing caffeine action on insulin sensitivity: effects on rat skeletal muscle.
    Sacramento JF, Ribeiro MJ, Yubero S, Melo BF, Obeso A, Guarino MP, Gonzalez C, Conde SV.
    Eur J Pharm Sci; 2015 Apr 05; 70():107-16. PubMed ID: 25661425
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.
    Holtzman SG.
    Life Sci; 1991 Apr 05; 49(21):1563-70. PubMed ID: 1943461
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The role of dopamine in the behavioral effects of caffeine in animals and humans.
    Garrett BE, Griffiths RR.
    Pharmacol Biochem Behav; 1997 Jul 05; 57(3):533-41. PubMed ID: 9218278
    [Abstract] [Full Text] [Related]

  • 54. Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.
    Casas M, Prat G, Robledo P, Barbanoj M, Kulisevsky J, Jané F.
    Eur Neuropsychopharmacol; 1999 Dec 05; 9(6):515-21. PubMed ID: 10625120
    [Abstract] [Full Text] [Related]

  • 55. Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.
    Finn IB, Holtzman SG.
    Psychopharmacology (Berl); 1987 Dec 05; 93(4):428-34. PubMed ID: 3124175
    [Abstract] [Full Text] [Related]

  • 56. What knock-out animals tell us about the effects of caffeine.
    Chen JF, Yu L, Shen HY, He JC, Wang X, Zheng R.
    J Alzheimers Dis; 2010 Dec 05; 20 Suppl 1():S17-24. PubMed ID: 20182058
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.